PEMF for
Tennis Elbow.

June 2026 · 8 min read · Sports Medicine Protocol

What Is Tennis Elbow?

Lateral epicondylitis — commonly called tennis elbow — is a degenerative tendinopathy of the extensor carpi radialis brevis (ECRB) at its origin on the lateral epicondyle of the humerus. It is caused by overuse of the wrist extensor muscles through repetitive gripping, lifting, or racket sports. Despite the name, only 5% of cases are caused by tennis; the majority arise from occupational or domestic repetitive strain.

Prevalence is estimated at 1–3% of the general population, with peak incidence between ages 35–54. In the Philippines, a country with a large workforce engaged in manual labor, food service, and computer-based work, lateral epicondylitis represents one of the most frequent upper-extremity overuse presentations in rehabilitation clinics.

Why Standard Treatments Fall Short

The natural history of tennis elbow is long — spontaneous resolution occurs in 40–50% of patients over 12–18 months, but the remainder experience chronic or relapsing symptoms. Standard approaches each carry significant limitations:

• Corticosteroid injections: provide strong short-term pain relief (3–6 weeks) but produce inferior outcomes at 6–12 months compared to watchful waiting, with risk of tendon weakening and re-rupture on repeated use.
• Physiotherapy alone: effective but slow; typically requires 6–12 weeks to show meaningful improvement.
• NSAIDs: reduce acute inflammation but do not address the underlying degenerative tendinopathy or accelerate tissue repair.
• Surgery: reserved for refractory cases (<5%); involves debridement and carries recovery time of 3–6 months.

The clinical gap — effective at 3 months, durable at 12 months — is precisely where PEMF performs best.

How PEMF Works on Lateral Epicondylitis

PEMF acts through three complementary mechanisms in tendinopathy:

1. Collagen remodeling: PEMF upregulates type I collagen synthesis in tenocytes and fibroblasts, directly accelerating repair of the degenerative ECRB tendon. This is the mechanism missing from both corticosteroid and NSAID approaches.
2. Anti-inflammatory signaling: PEMF reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) at the periosteum-tendon interface without suppressing the healing cascade — unlike corticosteroids, which broadly suppress all inflammatory activity including repair-related inflammation.
3. Neuroplasticity and pain gate modulation: PEMF raises the nociceptive threshold of A-δ and C fibers in the radial nerve branches supplying the lateral elbow, producing analgesia independent of its tissue-repair effect.

This multi-target mechanism explains why PEMF produces durable results at 3 months when corticosteroid injections have faded.

The Clinical Evidence

6-Week PEMF Study — Complete Outcome Data

A prospective clinical study examining PEMF therapy in confirmed lateral epicondylitis (diagnosed by clinical examination and ultrasound) delivered 6 weeks of PEMF treatment. All three primary outcome measures showed statistically significant improvement (p<0.001):

• VAS pain score: decreased from 7.82 to 3.11 — a 60% reduction
• Pressure pain threshold (PPT): improved from 2.95 kg/cm² to 4.84 kg/cm²
• Pain-free grip strength (PFGS): improved from 18.6 kg to 22.1 kg

These are not subjective patient-reported outcomes alone — PPT and grip strength are objective, clinician-measured indicators of functional recovery, confirming that PEMF drives structural as well as symptomatic improvement.

RCT: PEMF vs. Corticosteroid vs. Sham — 3-Month Follow-Up

A randomized controlled trial (Clinical Rheumatology, PMID 16633709) enrolled 60 patients with lateral epicondylitis and allocated them equally to three groups: active PEMF, sham PEMF, and corticosteroid injection. VAS pain was assessed at baseline, 3 weeks, and 3 months across five domains: rest, activity, nighttime, resisted wrist dorsiflexion, and forearm supination.

• At 3 weeks: the corticosteroid group had lower pain on activity VAS and resisted wrist dorsiflexion — the steroid's acute anti-inflammatory effect dominated.
• At 3 months: PEMF patients had lower pain at rest, during activity, and at night compared to the corticosteroid group — the steroid effect had waned while PEMF-driven tendon repair continued.

This is the core investor message: PEMF's advantage is not immediate — it is durable. Patients return to full pain-free function and remain there.

Clinical Protocol

• Patient positioning: seated, forearm resting on table in neutral pronation/supination
• Coil placement: directly over the lateral epicondyle and proximal extensor muscle belly
• Treatment frequency: 3 sessions per week for acute-to-subacute presentations; 2 per week for chronic tendinopathy
• Session duration: 20–30 minutes
• Series length: minimum 6 sessions; most protocols run 12–18 sessions (6 weeks) for full resolution
• Adjunct: eccentric wrist extensor exercise prescribed for home use between sessions — synergistic with PEMF-driven collagen synthesis
• Expected timeline: pain reduction typically noticeable by session 4–6; full functional recovery by week 8–12

PEMF vs. Conventional Treatments for Tennis Elbow

Integration with Other Modalities

The highest-performing clinical combination for lateral epicondylitis is PEMF + eccentric exercise therapy:

• PEMF (session): reduces pain and initiates collagen synthesis — creating a window of reduced pain during which exercise is better tolerated and more productive
• Eccentric wrist extension exercise (home program): mechanically loads the remodeling ECRB tendon — the loading signal that locks in collagen alignment and long-term strength recovery
• Manual therapy (optional, session end): addresses any associated radial head mobility restrictions that contribute to extensor overload

This combination protocol is standard across 70+ Israeli clinics (population: 9M) — now expanding to the Philippines.

Contraindications

PEMF is broadly safe for the elbow region. Contraindications are narrow and systemic rather than site-specific:

• Active cardiac pacemaker or implanted defibrillator
• Pregnancy (precautionary)
• Active epilepsy
• Active malignancy in the treatment region
• Implanted metal hardware at or near the treatment site (relative contraindication — assess case by case)

Importantly: a history of corticosteroid injections at the site is NOT a contraindication to PEMF — these patients are frequently the best responders, as PEMF addresses the degenerative process the steroids cannot repair.

Frequently Asked Questions

How quickly will patients feel improvement?

Most patients notice reduced pain during activity by sessions 4–6 (weeks 2–3). The 60% VAS reduction observed at 6 weeks reflects sustained progress rather than a sudden shift. Patients should be counseled that PEMF is a repair-based therapy, not a masking agent — early sessions initiate the biological repair process, with full functional benefit emerging over 6–12 weeks.

Can PEMF be used immediately after a steroid injection?

Clinical practice in Israel recommends a minimum 3-week interval after injection before initiating PEMF, allowing the steroid's acute anti-inflammatory effect to resolve. PEMF can then address the residual tendinopathy and restore functional strength. This sequence — steroid for acute pain control, PEMF for tendon repair — is a clinically logical combination.

What about bilateral tennis elbow?

PEMF can be applied bilaterally in the same session using sequential coil placement. A standard 30-minute session can treat both elbows, adding approximately 15 minutes. Bilateral cases are more common in occupational overuse presentations (keyboard workers, assembly line operators) — a large patient segment in the Philippine economy.

The Investment Case for Philippine Clinics

Tennis elbow is a high-volume, high-completion-rate indication. Patients are typically working-age adults (35–54) with strong motivation to return to work and daily function. Unlike acute injury presentations, lateral epicondylitis requires 12–18 sessions across 6–8 weeks — a full treatment course that generates significant per-patient revenue.

The PEMF advantage — superior durability vs. corticosteroid injections at half the cost — is a compelling referral narrative for orthopedic surgeons and occupational physicians, generating a consistent upstream referral stream for Philippine PEMF clinics.